Home › NDC Lookup › RxCUI directory › RxCUI 728550

Ketoconazole 20 MG/ML Topical Foam — RxCUI 728550

RxNorm drug concept · Semantic clinical drug
RxCUI 728550 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI728550
Official nameKetoconazole 20 MG/ML Topical Foam
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asketoconazole 2 % Topical Foam
FDA products mapped8
Package NDCs mapped11
Reported Medicaid activity (SDUD)7,103 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ketoconazole Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product you've been given. The shampoo form is used to treat tinea versicolor — a fungal infection that creates lighter or darker blotchy patches, usually on the...
  • What exactly is this medication treating on my skin?
  • This is really common with tinea versicolor, and it doesn't mean the treatment failed. The fungal infection can be cleared up, but the skin takes time to even out its pigment — som...
  • My skin patches haven't gone back to normal color yet — is the treatment even working?
📖 Read our full Ketoconazole Topical guide →

🕸️ Concept Web — How Ketoconazole 20 MG/ML Topical Foam Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ketoconazole 20 MG/ML Topical Foam RxCUI 728550

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ketoconazole 6135
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Extina 728511
    • Ketodan 1300268
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ketoconazole Topical Foam 728549
    • Ketoconazole Topical Product 1160957
    • Ketoconazole Topical Foam [Extina] 729767
    • Ketoconazole Topical Foam [Ketodan] 1300270
    • Extina Topical Product 1173930
    • Ketodan Topical Product 1300271
    • Topical Foam 346285
    • Topical Product 1151122
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ketoconazole 20 MG/ML 330469
    • Ketoconazole 20 MG/ML Topical Foam [Extina] 729768
    • Ketoconazole 20 MG/ML Topical Foam [Ketodan] 1300272
    • Ketoconazole 20 MG/ML [Extina] 729766
    • Ketoconazole 20 MG/ML [Ketodan] 1300269

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ketoconazole 20 MG/ML SCDC · 330469
  • Ketoconazole Topical Foam SCDF · 728549
  • Ketoconazole Topical Product SCDG · 1160957

Brand-Name Concepts

  • Ketoconazole 20 MG/ML Topical Foam [Ketodan] SBD · 1300272
  • Ketoconazole 20 MG/ML Topical Foam [Extina] SBD · 729768
  • Ketoconazole 20 MG/ML [Extina] SBDC · 729766
  • Ketoconazole 20 MG/ML [Ketodan] SBDC · 1300269
  • Ketoconazole Topical Foam [Extina] SBDF · 729767
  • Ketoconazole Topical Foam [Ketodan] SBDF · 1300270
  • Extina Topical Product SBDG · 1173930
  • Ketodan Topical Product SBDG · 1300271
  • Extina BN · 728511
  • Ketodan BN · 1300268

📦 FDA Products & Package NDCs

8 products · 11 package NDCs
11 package NDCs map to RxCUI 728550 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
43538-0530-10 1 CAN in 1 CARTON (43538-530-10) / 100 g in 1 CAN Ketodan Medimetriks Pharmaceuticals, Inc. 2012-06-15
45802-0532-32 1 CANISTER in 1 CARTON (45802-532-32) / 50 g in 1 CANISTER ketoconazole Padagis Israel Pharmaceuticals Ltd 2011-08-30
45802-0532-33 1 CANISTER in 1 CARTON (45802-532-33) / 100 g in 1 CANISTER ketoconazole Padagis Israel Pharmaceuticals Ltd 2011-08-30
63629-8676-01 1 CANISTER in 1 CARTON (63629-8676-1) / 50 g in 1 CANISTER ketoconazole Bryant Ranch Prepack 2011-08-30
63629-8677-01 1 CANISTER in 1 CARTON (63629-8677-1) / 100 g in 1 CANISTER ketoconazole Bryant Ranch Prepack 2011-08-30
70700-0160-19 50 g in 1 CAN (70700-160-19) Ketoconazole Xiromed, LLC 2021-05-21
70700-0160-20 100 g in 1 CAN (70700-160-20) Ketoconazole Xiromed, LLC 2021-05-21
71335-2941-01 1 CANISTER in 1 CARTON (71335-2941-1) / 50 g in 1 CANISTER ketoconazole Bryant Ranch Prepack 2025-10-24
71335-2943-01 1 CANISTER in 1 CARTON (71335-2943-1) / 100 g in 1 CANISTER ketoconazole Bryant Ranch Prepack 2025-10-24
72162-1417-01 1 CANISTER in 1 CARTON (72162-1417-1) / 100 g in 1 CANISTER ketoconazole Bryant Ranch Prepack 2024-12-24
72162-1417-02 1 CANISTER in 1 CARTON (72162-1417-2) / 50 g in 1 CANISTER ketoconazole Bryant Ranch Prepack 2024-12-24
Observed labelers: Bryant Ranch Prepack (6) · Padagis Israel Pharmaceuticals Ltd (2) · Xiromed, LLC (2) · Medimetriks Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.